Topics

OSE Immunotherapeutics Reports 2019 Financial Results And Provides Business Update

13:04 EDT 26 Mar 2020 | FinanzNachrichten

Expectations for Potential Impact of COVID-19 on the Company's Clinical Development Activities Strong clinical progress in lead assets Tedopi, OSE-127 and BI 765063 Bispecific antibody platform Bi...

Original Article: OSE Immunotherapeutics Reports 2019 Financial Results And Provides Business Update

NEXT ARTICLE

More From BioPortfolio on "OSE Immunotherapeutics Reports 2019 Financial Results And Provides Business Update"

Quick Search

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...